Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

12 nov. 2020 16h01 HE | Source: Bionano Genomics

Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update

SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians...
11 nov. 2020 18h10 HE | Source: Bionano Genomics

Multi-Center Evaluation of Bionano Optical Genome Mapping by Cytogenetics Thought Leaders in the US Leads to Recommendation for Bionano’s Saphyr to Replace Karyotyping as First-Line Test for Detection and Identification of Structural and Copy Number Variants in Leukemia Patients

Saphyr detected all clinically relevant structural variants (SVs) and copy number variants (CNVs) in 100 AML samples making it 100% concordant with standard of careSaphyr also detected additional...
05 nov. 2020 08h00 HE | Source: Bionano Genomics

Largest Study To-Date Focused on Undiagnosed Genetic Disease Patients Reveals That Bionano’s Optical Genome Mapping Technology Can Diagnose Significantly More Patients Than Standard of Care Methods Alone

SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study led by scientists and clinicians from the Institute for Human Genetics and the...
27 oct. 2020 17h59 HE | Source: Bionano Genomics

Prowess of Bionano Genomics’ Saphyr System in Uncovering Novel Genetic Variations That Cause Cancer and Genetic Disease in Full Display at ASHG 2020

SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that human genetics researchers using the Saphyr system will present their results at the American...
26 oct. 2020 08h00 HE | Source: Bionano Genomics

Rockefeller University Scientist Uses Bionano Saphyr to Analyze Genomes of Patients and Animals Susceptible to COVID-19

SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Dr. Erich Jarvis, a Howard Hughes Medical Institute investigator at the Rockefeller University...
21 oct. 2020 08h00 HE | Source: Bionano Genomics

Bionano Genomics Releases Major Update to Its Suite of Software Tools That Simplifies Clinical Analysis, Reduces Time to Actionable Results and Makes Adoption by Clinical Labs Easier

SAN DIEGO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) announces the most significant update to its suite of software tools for data analysis since the launch of Saphyr in...
15 oct. 2020 16h30 HE | Source: Bionano Genomics

Bionano Genomics' Saphyr System Shown to be Indispensable for the Analysis of Certain Genetic Disease Causing Variants

SAN DIEGO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that a study led by scientists and clinicians from the Institute for Human Genetics at the UCSF School of...
15 oct. 2020 08h00 HE | Source: Bionano Genomics

Bionano Genomics to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 12

SAN DIEGO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific...
08 oct. 2020 08h00 HE | Source: Bionano Genomics

Bionano's Saphyr Plays Essential Role in Identifying Three Previously Unknown Genetic Mutation Types in Cancer in Study from Weill Cornell

SAN DIEGO, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that its Saphyr system played a key role in a research study by Marcin Imielinski, M.D., Ph.D.,...
05 oct. 2020 16h15 HE | Source: Bionano Genomics

Boston Children’s Hospital Is Using Bionano’s Saphyr To Study Children With Severe COVID-19 Disease

SAN DIEGO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that a team led by Drs. Catherine Brownstein, Director of the Molecular Genetics Core Facility, and...

Page précédente

Page suivante